Macrophage- and neutrophil- dominant arthritis in human IL-1α transgenic mice
暂无分享,去创建一个
Y. Toyama | N. Tada | K. Fujikawa | Harumoto Yamada | T. Kikuchi | S. Seki | Y. Niki | H. Takaishi
[1] L. Joosten,et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. , 1999, Journal of immunology.
[2] G. Kollias,et al. Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. , 1999, Journal of immunology.
[3] O. Majdic,et al. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. , 1998, Journal of immunology.
[4] G. Kollias,et al. DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. , 1997, Journal of immunology.
[5] D. Livingston,et al. INTERLEUKIN-1β CONVERTING ENZYME INHIBITION BLOCKS PROGRESSION OF TYPE II COLLAGEN-INDUCED ARTHRITIS IN MICE , 1996 .
[6] L. Joosten,et al. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. , 1996 .
[7] J. Kieffer,et al. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. B. van den Berg,et al. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. , 1995, The Journal of rheumatology.
[9] G. Kollias,et al. The type I interleukin‐1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF‐transgenic mice , 1995, European journal of immunology.
[10] M. Furue,et al. Selective regulation of ICAM‐1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells , 1994, European journal of immunology.
[11] P. Wooley,et al. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. , 1993, Arthritis and rheumatism.
[12] R. Locksley,et al. The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Lövgren,et al. The induction of cell‐associated and secreted IL‐1 by iscoms, matrix or micelles in murine splenic cells , 1993, Clinical and experimental immunology.
[14] N. Miyasaka,et al. Detection of myeloid precursors (granulocyte/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints. , 1992, The Journal of rheumatology.
[15] M. Feldmann,et al. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. , 1992, British journal of rheumatology.
[16] P. Linsley,et al. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations , 1992, The Journal of experimental medicine.
[17] M. Elliott,et al. The excess numbers of peritoneal macrophages in granulocyte-macrophage colony-stimulating factor transgenic mice are generated by local proliferation , 1992, The Journal of experimental medicine.
[18] S. Yoshino,et al. Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats , 1992, The Journal of experimental medicine.
[19] H. Spits,et al. IL-1, IL-4, and IFN-gamma differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. , 1991, Journal of immunology.
[20] D. Kioussis,et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.
[21] D. Longo,et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. , 1991, Journal of immunology.
[22] P. Ghezzi,et al. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. , 1990, The Journal of infectious diseases.
[23] W. V. D. Berg,et al. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. , 1990, Annals of the rheumatic diseases.
[24] D. Longo,et al. Interleukin-1 enhances survival of lethally irradiated mice treated with allogeneic bone marrow cells , 1989 .
[25] G. Bagby. Interleukin-1 and hematopoiesis. , 1989, Blood reviews.
[26] S. Durum,et al. Membrane IL-1: IL-1 alpha precursor binds to the plasma membrane via a lectin-like interaction. , 1989, Journal of immunology.
[27] M. Moore,et al. Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. , 1989, Blood.
[28] L. Butler,et al. The progression of the inflammation in established collagen‐induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities , 1988, European journal of immunology.
[29] H. Colten,et al. The precursor of interleukin-1 alpha is phosphorylated at residue serine 90. , 1988, The Journal of biological chemistry.
[30] R. Jonsson,et al. Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[31] B Henderson,et al. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Dinarello,et al. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. , 1986, The Journal of clinical investigation.
[33] R. Russell,et al. An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.
[34] P. Lipsky,et al. The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen. , 1983, Journal of immunology.
[35] C. Dinarello,et al. Molecular basis of fever in humans. , 1982, The American journal of medicine.
[36] J. Caulfield,et al. Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[37] S. Krane,et al. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[38] K. Paigen,et al. A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.
[39] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[40] C. Dinarello,et al. Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen , 1978, The Journal of experimental medicine.
[41] L. Rosenwasser,et al. Adherent cell function in murine T lymphocyte antigen recognition. II. Definition of genetically restricted and nonrestricted macrophage functions in T cell proliferation. , 1978, Journal of immunology.
[42] M. Ziff,et al. Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. , 1975, Arthritis and rheumatism.